Patents by Inventor Melanie Bennett

Melanie Bennett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
    Patent number: 7329650
    Abstract: The present invention relates to peptides and peptide analogues designed from HFE protein. In particular, it relates to peptides and peptide analogues designed from an alpha-1 region of HFE protein which lowers the binding affinity of transferrin receptor for transferrin. Such compounds mimic HFE protein function, and reduce iron uptake and/or accumulation by a cell.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: February 12, 2008
    Assignees: Bio-Rad Laboratories, Inc., California Institute of Technology
    Inventors: John N. Feder, Randall C. Schatzman, Pamela J. Bjorkman, Melanie Bennett, Jose Lebron
  • Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
    Publication number: 20050282754
    Abstract: The present invention relates to peptides and peptide analogues designed from HFE protein. In particular, it relates to peptides and peptide analogues designed from an alpha-1 region of HFE protein which lowers the binding affinity of transferrin receptor for transferrin. Such compounds mimic HFE protein function, and reduce iron uptake and/or accumulation by a cell.
    Type: Application
    Filed: July 18, 2005
    Publication date: December 22, 2005
    Inventors: John Feder, Randall Schatzman, Pamela Bjorkman, Melanie Bennett, Jose Lebron
  • Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
    Patent number: 6924265
    Abstract: The present invention relates to peptides and peptide analogues designed from HFE protein. In particular, it relates to peptides and peptide analogues designed from an alpha-1 region of HFE protein which lowers the binding affinity of transferrin receptor for transferrin. Such compounds mimic HFE protein function, and reduce iron uptake and/or accumulation by a cell.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: August 2, 2005
    Assignees: Bio-Rad Laboratories, Inc., California Institute of Technology
    Inventors: John N. Feder, Randall C. Schatzman, Pamela J. Bjorkman, Melanie Bennett, Jose Lebron
  • Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
    Publication number: 20020165162
    Abstract: The present invention relates to peptides and peptide analogues designed from HFE protein. In particular, it relates to peptides and peptide analogues designed from an alpha-1 region of HFE protein which lowers the binding affinity of transferrin receptor for transferrin. Such compounds mimic HFE protein function, and reduce iron uptake and/or accumulation by a cell.
    Type: Application
    Filed: July 9, 2001
    Publication date: November 7, 2002
    Applicant: Bio-Rad Laboratories, Inc.
    Inventors: John N. Feder, Randall C. Schatzman, Pamela J. Bjorkman, Melanie Bennett, Jose Lebron
  • Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
    Patent number: 6284732
    Abstract: The present invention relates to peptides and peptide analogues designed from HFE protein. In particular, it relates to peptides and peptide analogues designed from an alpha-1 region of HFE protein which lowers the binding affinity of transferrin receptor for transferrin. Such compounds mimic HFE protein function, and reduce iron uptake and/or accumulation by a cell.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: September 4, 2001
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: John N. Feder, Randall C. Schatzman, Pamela J. Bjorkman, Melanie Bennett, Jose Lebron